Letter to the Editor

Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

Giuseppe Giannaccare, Marina Buzzi, Piera Versura
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-11-07
Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9

Albert Farrugia
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-04-04
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain

Arturo Pereira, Julio del Río-Garma, José A. García-Erce
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-12-22
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"

Andrea Messori, Flora Peyvandi, Sabrina Trippoli, Roberta Palla, Frits R. Rosendaal, Pier Mannuccio Mannucci
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-10-03
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.

Albert Farrugia, Megha Bansal
Issue: Blood Transfusion - 1 2018 (January - February) Publication Date: 2016-09-22
Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light

Per Sandgren

Submit an Article

Information